Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ADA 2026 5 - 8 June 2026

Longitudinal Dynamics of Cardiometabolic Parameters in a MASH Population Stratified by Baseline Glycemia and Treated with Semaglutide: Post Hoc Insights from the ESSENCE Trial Part 1

Authors :

Mary E. Rinella1; Maria Teresa Arias-Loste2; Elisabetta Bugianesi3; Laurent Castera4,5;Nathalie M. Eklöf6; Won Kim7; Niels Krarup8; Bernhard Ludvik; Philip N. Newsome9,10; Vlad Ratziu11;Arun J. Sanyal12; Anca Trifan13; Thea C. Vestergaard6;Michael Roden14-16;

Affiliations
View Details Hide Details
Download .PDF
Keywords
MASH
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)